- Home
- IMCC vs EVAX Comparison
IMCC vs EVAX Comparison
Compare IMCC & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- EVAX
- Stock Information
- Founded
- IMCC 1980
- EVAX 2008
- Country
- IMCC Israel
- EVAX Denmark
- Employees
- IMCC N/A
- EVAX N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMCC Health Care
- EVAX Health Care
- Exchange
- IMCC Nasdaq
- EVAX Nasdaq
- Market Cap
- IMCC 12.2M
- EVAX 17.8M
- IPO Year
- IMCC N/A
- EVAX 2021
- Fundamental
- Price
- IMCC $1.93
- EVAX $2.90
- Analyst Decision
- IMCC
- EVAX Strong Buy
- Analyst Count
- IMCC 0
- EVAX 2
- Target Price
- IMCC N/A
- EVAX $10.00
- AVG Volume (30 Days)
- IMCC 70.0K
- EVAX 89.0K
- Earning Date
- IMCC 11-13-2025
- EVAX 10-30-2025
- Dividend Yield
- IMCC N/A
- EVAX N/A
- EPS Growth
- IMCC N/A
- EVAX N/A
- EPS
- IMCC N/A
- EVAX N/A
- Revenue
- IMCC $38,430,631.00
- EVAX $3,176,000.00
- Revenue This Year
- IMCC $47.12
- EVAX N/A
- Revenue Next Year
- IMCC $12.83
- EVAX N/A
- P/E Ratio
- IMCC N/A
- EVAX N/A
- Revenue Growth
- IMCC 5.08
- EVAX 1042.45
- 52 Week Low
- IMCC $1.29
- EVAX $1.20
- 52 Week High
- IMCC $7.12
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- IMCC 37.90
- EVAX 50.88
- Support Level
- IMCC $1.74
- EVAX $2.71
- Resistance Level
- IMCC $2.03
- EVAX $3.04
- Average True Range (ATR)
- IMCC 0.25
- EVAX 0.20
- MACD
- IMCC -0.00
- EVAX -0.01
- Stochastic Oscillator
- IMCC 39.75
- EVAX 55.97
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.